Rare variants in the TREX1 gene and susceptibility to autoimmune diseases

Abstract

TREX1 (DNase III) is an exonuclease involved in response to oxidative stress and apoptosis. Heterozygous mutations in TREX1 were previously observed in patients with systemic lupus erythematosus (SLE) and Sjögren's syndrome (SS). We performed a mutational analysis of the TREX1 gene on three autoimmune diseases: SLE (210 patients) and SS (58 patients), to confirm a TREX1 involvement in the Italian population, and systemic sclerosis (SSc, 150 patients) because it shares similarities with SLE (presence of antinuclear antibodies and connective tissue damage). We observed 7 variations; two of these are novel nonsynonymous variants (p.Glu198Lys and p.Met232Val). They were detected in one SS and in one SSc patient, respectively, and in none of the 200 healthy controls typed in this study and of the 1712 published controls. In silico analysis predicts a possibly damaging role on protein function for both variants. The other 5 variations are synonymous and only one of them is novel (p.Pro48Pro). This study contributes to the demonstration that TREX1 is involved in autoimmune diseases and proposes that the spectrum of involved autoimmune diseases can be broader and includes SSc. We do not confirm a role of TREX1 variants in SLE.

Figure 1

Scheme of disease-associated TREX1 mutations so far reported in literature. The two missense mutations found in the present study are in squares. Normal type, black: AGS; italic, green: RVCL; underlined, italic, green: CADASIL; underlined black: FCL; boldface, red: SLE; boldface, pink: SSc; boldface, blue: SS. Exo 1, 2, 3 domains; PII: polyproline II domain; TMH: transmembrane domain.